Pathogenesis of multi-organic failure in autoimmune diseases

Autoimmunity Reviews

Volumn 8, Issue 6, 2009, Pages 525-528

  Amaral, M C ^a   Alves, J Delgado ^a  

^a HOSPITAL CURRY CABRAL   (Portugal)

Author keywords

Anti CD28 antibody; Macrophage activation syndrome; Multi organic failure

Indexed keywords

COMPLEMENT; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DACLIZUMAB; ETANERCEPT; GOLD SALT; IMMUNOGLOBULIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; KININ; METHOTREXATE; MONOCLONAL ANTIBODY CD28; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE; STEROID; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TGN 1412;

AUTOIMMUNE DISEASE; BLOOD CLOTTING; CLINICAL TRIAL; CYTOKINE RELEASE; DIARRHEA; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG DOSE ESCALATION; DRUG MEGADOSE; ENDOTHELIUM CELL; ERYTHEMA; FEEDBACK SYSTEM; FEVER; FIBRINOLYSIS; HEADACHE; HUMAN; HYPOTENSION; KIDNEY DYSFUNCTION; LUNG INFILTRATE; MACROPHAGE ACTIVATION SYNDROME; MULTIPLE CYTOKINE RELEASE SYNDROME; MULTIPLE ORGAN FAILURE; MYALGIA; NAUSEA; PATHOGENESIS; RESPIRATORY DISTRESS; REVIEW; SYNDROME;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD28; AUTOIMMUNE DISEASES; BLOOD COAGULATION; CHILD; CLINICAL TRIALS AS TOPIC; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; FEEDBACK, BIOCHEMICAL; HUMANS; MACROPHAGE ACTIVATION SYNDROME; MULTIPLE ORGAN FAILURE; SIGNAL TRANSDUCTION; THROMBOSIS;

EID: 67349126916     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2009.01.009     Document Type: Review

References (20)

1. Pober J.S., and Cotran R.S. Overview: the role of endothelial cells in inflammation. Transplantation 90 (1990) 537
2. Morgan B.P. Physiology and pathophysiology of complement: progress and trends. Crit Rev Clin Lab Sci 32 (1995) 265-298
3. Margolius H.S. Kallikreins and kinins: some unanswered questions about system characteristics and roles in human disease. Hypertension 26 (1995) 221-229
4. Carmeliet P., and Collen D. Molecular genetics of the fibrinolytic and coagulation systems in haemostasis, thrombogenesis, restenosis and atherosclerosis. Curr Opin Lipidol 8 (1997) 118-125
5. Cirino G., Cicala C., Bucci M., Sorrentino L., Ambrosini G., DeDominicis G., et al. Factor Xa as an interface between coagulation and inflammation. Molecular mimicry of factor Xa association with effector cell protease receptor-1 induces acute inflammation in vivo. J Clin Invest 99 (1997) 2446-2451
6. Premack B.A., and Schall T.J. Chemokine receptors: gateways to inflammation and infection. Nat Med 2 (1996) 1174-1178
7. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 87 (1996) 2095-2147
8. Akira S., Takeda K., and Kaisho T. Toll-like receptors: critical proteins linking the innate and acquired immunity. Nat Immunol 2 (2001) 675-680
9. Favara B.E., Feller C.A., Paulli M., Jaffe E.S., Weiss L.M., Arico M., et al. Contemporary classification of histiocytic disorders. Med Pediatr Oncol 29 (1997) 157-166
10. Sawhney S., Woo P., and Murray K.J. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child 85 (2001) 421-426
11. Ravelli A., Caria M.C., Buratti S., Malattia C., Temporini F., and Martini A. Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis. J Rheumatol 28 (2001) 865-867
12. De Benedetti F., Pignatti P., Massa M., Sartirana P., Ravelli A., Cassani G., et al. Soluble tumour necrosis factor receptor levels reflect coagulation abnormalities in systemic juvenile chronic arthritis. Br J Rheumatol 36 (1997) 581-588
13. Stepp S.E., Dufourcq-Lagelouse R., Le Deist F., Bhawan S., Certain S., Mathew P.A., et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 286 (1999) 1957-1959
14. Behrens E.M. Macrophage Activation Syndrome in rheumatic disease: what is the role of the antigen presenting cell?. Autoimmun Rev 7 (2008) 305-308
15. Ravelli A. Macrophage activation syndrome. Curr Opin Rheumatol 14 (2002) 548-552
16. Mouy R., Stephan J.-L., Pillet P., Haddad E., Hubert P., and Prieur A.-M. Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases. J Pediatr 129 (1996) 750-754
17. Makay B., Yilmaz S., Türkyilmaz Z., Ünal N., Ören H., and Ünsal E. Etanercept for therapy-resistant macrophage activation syndrome. Pediatr Blood Cancer 50 (2008) 419-421
18. Berg M., and Zavazava N. Regulation of CD28 expression on CD8+ T cells by CTLA-4. J Leukoc Biol 83 (2008) 1-11
19. Hünig T., and Dennehy K. CD28 superagonists: mode of function and therapeutic potential. Immunol Letters 100 (2005) 21-28
20. Suntharalingam G., Perry M.R., Ward S., Brett S.J., Castello-Cortes A., Brunner M.D., et al. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med 355 (2006) 1018-1028